103
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Factors associated with sex-trade involvement among female injection drug users in a Canadian setting

, , , , , , , & show all
Pages 193-199 | Accepted 15 Feb 2005, Published online: 11 Jul 2009

References

  • Craib, K. J., Spittal, P. M., Wood, E., Laliberte, N., Hogs, R. S., Li, K., Heath, K., Tyndall, M. W., O’Shaughnessy, M. W., & Schechter, M. T. (2003). Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ, 168(1), 19–24.
  • Culbert, L. (2003). Pickton to stand trial for murder in deaths of 15 sex-trade workers: Crown prepares seven additional counts based on new evidence. The Vancouver Sun, Vancouver.
  • Culhane, D. P., Gollub, E., Kuhn, R., & Shpaner, M. (2001). The co-occurrence of AIDS and homelessness: Results from the integration of administrative databases for AIDS surveillance and public shelter utilisation in Philadelphia. Journal of Epidemiology and Community Health, 55(7), 515–20.
  • Des Jarlais, D. C., Paone, D., Milliken, J., Turner, C. F., Miller, H., Bribble, J., Shi, Q., Hagen, H., & Friedman, S. R. (1999). Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet, 353(9165), 1657–61.
  • Latkin, C. A., Mandell, W., & Spittal, P. M. (1996). The relationship between risk networks’ patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: A prospective study. Drug Alcohol Depend, 42(3), 175–81.
  • Latkin, C. A., & Vlahov, D. (1998). Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction, 93(8), 1191–7.
  • Liang, K. Y., & Zeger, S. L. (1986). Longitudinal data using generalized linear models. Biometrika, 73, 13–22.
  • Miller, C. L., Johnston, C., Spittal, P. M., Li, K., Laliberte´, N., Montaner, J. S. G., & Schechter, M. T. (2002). Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users.
  • Hepatology, 36(3), 737–42.
  • O’Shaughnessy, M. V., Montaner, J. S. G., Strathdee, S., & Schechter, M. T. (1998). Deadly public policy. International Conference on AIDS, Geneva, Switzerland.
  • Spittal, P. M., Bruneau, J., Craib, K. J. P., Miller, C., Lamothe, F., Weber, A. E., Li, K., Tyndall, M. W., O’Shaughnessy, M. V., & Schechter, M. T. (2003). Surviving the sex trade: A comparison of HIV risk beha- viours among street-involved women in two Canadian cities who inject drugs. AIDS Care, 15(2), 187–95.
  • Spittal, P. M., Craib, K. J. P., Wood, E., Laliberte´, N., Li, K., Tyndall, M. W., O’Shaughnessy, M. V., & Schechter, M. T. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ, 166(7), 894–9.
  • PIVOT Legal Society Sex Work Subcommittee (2003). Voices for dignity: A call to end the harms caused by Canada’s sex trade laws. Pivot Legal Society, Vancouver.
  • Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O’Shaughnessy, M. V., & Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17(6), 887–93.
  • Wood, E., Spittal, P. M., Li, K., Kerr, T., Miller, C. L., Hogg, R. S., Montaner, J. S. G., & Schechter, M. T. (2003). The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes, 32(1), 2–8.
  • Wood, E., Spittal, P. M., Li, K., Kerr, T., Miller, C. L., Hogg, R. S., Montaner, J. S. G., & Schechter, M. T. (2004). Inability to access addiction treatment and risk of HIV-infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, 36(2), 750–754.
  • Zeger, S. L., & Liang, K. Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42(1), 121–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.